trifluperidol has been researched along with Idiopathic Parkinson Disease in 2 studies
Trifluperidol: A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in the treatment of PSYCHOSES including MANIA and SCHIZOPHRENIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p621)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin, IC | 1 |
| Marino, A | 1 |
1 trial available for trifluperidol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Delayed-Action Preparat | 1975 |
1 other study available for trifluperidol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
[Parkinsonian and neurodysleptic syndromes during treatment with neuroleptic drugs].
Topics: Adolescent; Adult; Female; Haloperidol; Humans; Male; Middle Aged; Parkinson Disease; Psychotic Diso | 1965 |